CADTH is committed to supporting Canada’s health care decision-makers through this challenging and uncertain time.
For evidence, tools, and resources related to COVID-19, visit our COVID-19 Evidence Portal.

 

Begin main content

Umeclidinium/vilanterol

Last Updated: February 26, 2014
Result type: Reports
Project Number: SR0371-000
Product Line: Common Drug Review

Generic Name: Umeclidinium/vilanterol

Brand Name: Anoro Ellipta

Manufacturer: GlaxoSmithKline Inc.

Indications: Chronic Obstructive Pulmonary Disease

Submission Type: New

Project Status: Complete

Date Recommendation Issued: January 15, 2015

Recommendation Type: List with criteria/condition